Journal article
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.
Abstract
BACKGROUND: Brachytherapy (permanent implantation of radioactive seeds) has emerged as an alternative to existing standard therapy with radical prostatectomy or external beam radiotherapy in the treatment of clinically localized (T1 and T2) prostate cancer. The Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative examined the role of brachytherapy in treating clinically localized prostate cancer.
Authors
Crook J; Lukka H; Klotz L; Bestic N; Johnston M
Journal
Canadian Medical Association Journal, Vol. 164, No. 7, pp. 975–981
Publication Date
April 3, 2001
ISSN
0820-3946